Homepage

Homepage

Header Image Multifield: 
Header Image: 
Opportunities for Honours, Masters and PhD study
Header Image: 
Jacques Miller Lasker Award graphic
Header Image: 
Christmas appeal promotional banner

Welcome to the Walter and Eliza Hall Institute of Medical Research

Super Content: 
Scientist in the National Drug Discovery Centre

Fast-tracking new medicines

The National Drug Discovery Centre (NDDC) is open to the Australian medical research community.

With the NDDC researchers have access to advanced high-throughput screening and the latest robotic technologies in a fully staffed facility.

Apply for an Australian government-subsidised screening campaign, and fast track your discoveries into new medicines.
 

Learn more

 

News

Female researcher smiling at camera International team discovers new human autoinflammatory disease

Scientists from Australia and the US have discovered and identified the genetic cause of a previously unknown human autoinflammatory disease.

12 December 2019
read more
Two scientists smiling at camera, standing in front of purple screen New genetic cause of epilepsy found

Researchers from the Walter and Eliza Hall Institute have contributed to a decades-long global effort that has revealed two new gene mutations that cause a rare type of epilepsy.

9 December 2019
read more
Animation of tumour growing in breast tissue $3.5M ACRF grant to tackle cancer complexity

Walter and Eliza Hall Institute researchers have won a $3.5 million ACRF grant to conquer the biggest challenges in cancer today – predicting and improving patients’ treatment response and overcoming drug resistance.

28 November 2019
read more
Researchers standing together CSL Florey Medal recognises cell death research pioneers

Professor David Vaux AO and Professor Andreas Strasser have been jointly awarded the 2019 CSL Florey Medal for establishing a new field of research – the molecular biology of programmed cell death.

27 November 2019
read more

Events

Mon, 16/12/2019 - 3:00pm to Mon, 16/12/2019 - 4:00pm

Identifying and overcoming therapeutic resistance in high-risk acute lymphoblastic leukaemia

Tue, 17/12/2019 - 10:00am to Tue, 17/12/2019 - 11:00am

​A new target to enhance the efficacy of cancer immunotherapy? Intratumoral HMGB1 controls the anticancer immune response

Wed, 18/12/2019 - 11:00am to Wed, 18/12/2019 - 12:00pm

​Origins and evolution of transmissible cancers

Thu, 19/12/2019 - 1:00pm to Thu, 19/12/2019 - 2:00pm

​Alterations in B cell signaling thresholds impacting the pathogenesis of humoral autoimmunity

Empty

Empty